{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:21:21Z","timestamp":1792279281888,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T00:00:00Z","timestamp":1626566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.leukres.2021.106669","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T11:45:09Z","timestamp":1626435909000},"page":"106669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma\/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study"],"prefix":"10.1016","volume":"111","author":[{"given":"Yunxia","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2904-8249","authenticated-orcid":false,"given":"Xiumei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2021.106669_bib0005","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"11","key":"10.1016\/j.leukres.2021.106669_bib0010","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin\u2019s lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"issue":"26","key":"10.1016\/j.leukres.2021.106669_bib0015","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska","year":"2017","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.leukres.2021.106669_bib0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3324\/haematol.2016.152256","article-title":"Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association","volume":"102","author":"Sarkozy","year":"2017","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.leukres.2021.106669_bib0025","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","article-title":"Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations","volume":"24","author":"Eberle","year":"2011","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.leukres.2021.106669_bib0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3324\/haematol.2010.033167","article-title":"Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin\u2019s lymphoma and primary mediastinal large B-cell lymphoma","volume":"96","author":"Eberle","year":"2011","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.leukres.2021.106669_bib0035","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1182\/blood-2014-03-564906","article-title":"A prospective study of mediastinal gray-zone lymphoma","volume":"124","author":"Wilson","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2021.106669_bib0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bjh.17327","article-title":"Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group","volume":"193","author":"Eichenauer","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"18","key":"10.1016\/j.leukres.2021.106669_bib0045","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1002\/cncr.28194","article-title":"Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors","volume":"119","author":"Xavier","year":"2013","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.leukres.2021.106669_bib0050","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3324\/haematol.2017.167478","article-title":"Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials","volume":"102","author":"Eichenauer","year":"2017","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.leukres.2021.106669_bib0055","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1200\/JCO.2001.19.7.2026","article-title":"Non-Hodgkin\u2019s lymphoma after primary Hodgkin\u2019s disease in the German Hodgkin\u2019s Lymphoma Study Group: incidence, treatment, and prognosis","volume":"19","author":"Rueffer","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106669_bib0060","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bjh.16331","article-title":"Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma\/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases","volume":"189","author":"Aussedat","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.leukres.2021.106669_bib0065","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ajh.24082","article-title":"Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort","volume":"90","author":"Evens","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106669_bib0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2014-05-575092","article-title":"Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?","volume":"125","author":"Dunleavy","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2021.106669_bib0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/modpathol.2011.200","article-title":"The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases","volume":"25","author":"Gualco","year":"2012","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.leukres.2021.106669_bib0080","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2021.106669_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2019.100502","article-title":"Second primary malignancy in diffuse large B-cell lymphoma patients: a SEER database analysis","volume":"44","author":"Jiang","year":"2020","journal-title":"Curr. Probl. Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2021.106669_bib0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00000478-199302000-00004","article-title":"Hodgkin\u2019s disease following non-Hodgkin\u2019s lymphoma. A clinicopathologic and immunophenotypic study of nine cases","volume":"17","author":"Zarate-Osorno","year":"1993","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106669_bib0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3960\/jslrt.50.143","article-title":"Two cases of mediastinal gray zone lymphoma","volume":"50","author":"Minami","year":"2010","journal-title":"J. Clin. Exp. Hematop."},{"issue":"34","key":"10.1016\/j.leukres.2021.106669_bib0100","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2010.29.5683","article-title":"Long-term survival among patients with Hodgkin\u2019s lymphoma who developed breast cancer: a population-based study","volume":"28","author":"Milano","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.leukres.2021.106669_bib0105","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1002\/cncr.26257","article-title":"Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients","volume":"117","author":"Milano","year":"2011","journal-title":"Cancer"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:27Z","timestamp":1758934887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621001703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":21,"alternative-id":["S0145212621001703"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106669","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma\/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106669"}}